425 related articles for article (PubMed ID: 12473595)
61. Current evidence on the relationship between four polymorphisms in the matrix metalloproteinases (MMP) gene and breast cancer risk: a meta-analysis.
Zhou P; Du LF; Lv GQ; Yu XM; Gu YL; Li JP; Zhang C
Breast Cancer Res Treat; 2011 Jun; 127(3):813-8. PubMed ID: 21161369
[TBL] [Abstract][Full Text] [Related]
62. Synergistic effect of collagenase-1 (MMP1), stromelysin-1 (MMP3) and gelatinase-B (MMP9) gene polymorphisms in breast cancer.
Padala C; Tupurani MA; Puranam K; Gantala S; Shyamala N; Kondapalli MS; Gundapaneni KK; Mudigonda S; Galimudi RK; Kupsal K; Nanchari SR; Chavan U; Chinta SK; Mukta S; Satti V; Hanumanth SR
PLoS One; 2017; 12(9):e0184448. PubMed ID: 28961241
[TBL] [Abstract][Full Text] [Related]
63. Intrinsic genetic characteristics determine tumor-modifying capacity of fibroblasts: matrix metalloproteinase-3 5A/5A genotype enhances breast cancer cell invasion.
Holliday DL; Hughes S; Shaw JA; Walker RA; Jones JL
Breast Cancer Res; 2007; 9(5):R67. PubMed ID: 17922906
[TBL] [Abstract][Full Text] [Related]
64. The collagenase-1 (MMP-1) gene promoter polymorphism - 1607/2G is associated with favourable prognosis in patients with colorectal cancer.
Hettiaratchi A; Hawkins NJ; McKenzie G; Ward RL; Hunt JE; Wakefield D; Di Girolamo N
Br J Cancer; 2007 Mar; 96(5):783-92. PubMed ID: 17311017
[TBL] [Abstract][Full Text] [Related]
65. Current evidence on the relationship between five polymorphisms in the matrix metalloproteinases (MMP) gene and lung cancer risk: a meta-analysis.
Hu C; Wang J; Xu Y; Li X; Chen H; Bunjhoo H; Xiong W; Xu Y; Zhao J
Gene; 2013 Mar; 517(1):65-71. PubMed ID: 23313298
[TBL] [Abstract][Full Text] [Related]
66. The association of the metalloproteinase-3 gene promoter polymorphisms and the middle cerebral artery stenosis.
Fu C; Xing Y; Song X
Cell Biochem Biophys; 2011 Apr; 59(3):185-9. PubMed ID: 21113741
[TBL] [Abstract][Full Text] [Related]
67. Polymorphisms of genes involved in extracellular matrix remodeling and abdominal aortic aneurysm.
Saracini C; Bolli P; Sticchi E; Pratesi G; Pulli R; Sofi F; Pratesi C; Gensini GF; Abbate R; Giusti B
J Vasc Surg; 2012 Jan; 55(1):171-179.e2. PubMed ID: 22094117
[TBL] [Abstract][Full Text] [Related]
68. Synergistic effect of stromelysin-1 (matrix metalloproteinase-3) promoter (-1171 5A->6A) polymorphism in oral submucous fibrosis and head and neck lesions.
Chaudhary AK; Singh M; Bharti AC; Singh M; Shukla S; Singh AK; Mehrotra R
BMC Cancer; 2010 Jul; 10():369. PubMed ID: 20630073
[TBL] [Abstract][Full Text] [Related]
69. Association of matrix metalloproteinase (MMP-1, MMP-3 and MMP-9) and cyclooxygenase-2 gene polymorphisms and their proteins with chronic periodontitis.
Loo WT; Wang M; Jin LJ; Cheung MN; Li GR
Arch Oral Biol; 2011 Oct; 56(10):1081-90. PubMed ID: 21481333
[TBL] [Abstract][Full Text] [Related]
70. Collagenase-1 (-1607 1G/2G), Gelatinase-A (-1306 C/T), Stromelysin-1 (-1171 5A/6A) functional promoter polymorphisms in risk prediction of type 2 diabetic nephropathy.
Gantala SR; Kondapalli MS; Kummari R; Padala C; Tupurani MA; Kupsal K; Galimudi RK; Gundapaneni KK; Puranam K; Shyamala N; Guditi S; Rapur R; Hanumanth SR
Gene; 2018 Oct; 673():22-31. PubMed ID: 29883760
[TBL] [Abstract][Full Text] [Related]
71. Promoter polymorphism MMP-1 (-1607 2G/1G) and MMP-3 (-1612 5A/6A) in development of HAND and modulation of pathogenesis of HAND.
Singh HO; Marathe SD; Nain S; Samani D; Nema V; Ghate MV; Gangakhedkar RR
J Biosci; 2017 Sep; 42(3):481-490. PubMed ID: 29358561
[TBL] [Abstract][Full Text] [Related]
72. Matrix metalloproteinase-3 and intracranial arterial dolichoectasia.
Pico F; Jacob MP; Labreuche J; Soufir N; Touboul PJ; Benessiano J; Cambien F; Grandchamp B; Michel JB; Amarenco P
Ann Neurol; 2010 Apr; 67(4):508-15. PubMed ID: 20437586
[TBL] [Abstract][Full Text] [Related]
73. Matrix metalloproteinase-2 promoter variability in psoriasis.
Vasku V; Bienertova Vasku J; Slonková V; Kanková K; Vasku A
Arch Dermatol Res; 2009 Jul; 301(6):467-73. PubMed ID: 19360430
[TBL] [Abstract][Full Text] [Related]
74. Impact of MMP-3 and TIMP-3 gene polymorphisms on prostate cancer susceptibility in North Indian cohort.
Srivastava P; Kapoor R; Mittal RD
Gene; 2013 Nov; 530(2):273-7. PubMed ID: 23872201
[TBL] [Abstract][Full Text] [Related]
75. Genetic polymorphisms of matrix metalloproteinases: susceptibility and prognostic implications for prostate cancer.
Dos Reis ST; Pontes J; Villanova FE; Borra PM; Antunes AA; Dall'oglio MF; Srougi M; Leite KR
J Urol; 2009 May; 181(5):2320-5. PubMed ID: 19303106
[TBL] [Abstract][Full Text] [Related]
76. Polymorphisms in the matrix metalloproteinase-1, 3, and 9 promoters and susceptibility to adult astrocytoma in northern China.
Lu Z; Cao Y; Wang Y; Zhang Q; Zhang X; Wang S; Li Y; Xie H; Jiao B; Zhang J
J Neurooncol; 2007 Oct; 85(1):65-73. PubMed ID: 17502998
[TBL] [Abstract][Full Text] [Related]
77. Functional polymorphism of the MMP-1 promoter (-1607 1G/2G) in potentially malignant and malignant head and neck lesions in an Indian population.
Chaudhary AK; Pandya S; Mehrotra R; Bharti AC; Jain S; Singh M
Biomarkers; 2010 Dec; 15(8):684-92. PubMed ID: 20860530
[TBL] [Abstract][Full Text] [Related]
78. A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter is associated with conventional renal cell carcinoma.
Hirata H; Naito K; Yoshihiro S; Matsuyama H; Suehiro Y; Hinoda Y
Int J Cancer; 2003 Sep; 106(3):372-4. PubMed ID: 12845675
[TBL] [Abstract][Full Text] [Related]
79. Influence of Matrix metalloproteinase 1 and 3 genetic variations on susceptibility and severity of juvenile idiopathic arthritis.
Abd-Allah SH; El-Shal AS; Shalaby SM; Pasha HF; Abou El-Saoud AM; Abdel Galil SM; Mahmoud TA
IUBMB Life; 2015 Dec; 67(12):934-42. PubMed ID: 26510114
[TBL] [Abstract][Full Text] [Related]
80. The Association of
Hsiao CL; Liu LC; Shih TC; Lai YL; Hsu SW; Wang HC; Pan SY; Shen TC; Tsai CW; Chang WS; Su CH; Way TD; Chung JG; Bau DT
In Vivo; 2018; 32(3):487-491. PubMed ID: 29695550
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
